Advisors Capital Management, LLC Exagen Inc. Transaction History

Advisors Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	BUY	$2.69 - $8.68 $72,764 - $234,794	27,050 Added 66.18%	67,923 $143,000
Q2 2022 Aug 12, 2022	BUY	$4.18 - $7.74 $4,614 - $8,544	1,104 Added 2.78%	40,873 $235,000
Q1 2022 May 10, 2022	BUY	$7.12 - $11.06 $16,027 - $24,896	2,251 Added 6.0%	39,769 $319,000
Q4 2021 Feb 14, 2022	BUY	$8.97 - $14.08 $48,760 - $76,538	5,436 Added 16.94%	37,518 $436,000
Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $52,582 - $78,027	5,130 Added 19.03%	32,082 $436,000
Q2 2021 Aug 02, 2021	SELL	$12.4 - $17.92 $40,982 - $59,225	-3,305 Reduced 10.92%	26,952 $404,000
Q1 2021 May 12, 2021	BUY	$13.9 - $22.0 $420,572 - $665,654	30,257 New	30,257 $529,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Capital Management, LLC with notifications on news.